Free Trial

Grail Q3 2024 Earnings Report

Grail logo
$40.73 -7.03 (-14.72%)
As of 02/21/2025 04:00 PM Eastern

Grail EPS Results

Actual EPS
-$3.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Grail Revenue Results

Actual Revenue
$28.65 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Grail Announcement Details

Quarter
Q3 2024
Time
After Market Closes

Grail Earnings Headlines

Why Grail (GRAL) Is Falling Today
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript
Grail Inc options imply 13.5% move in share price post-earnings
See More Grail Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Grail? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Grail and other key companies, straight to your email.

About Grail

Grail (NASDAQ:GRAL) is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

View Grail Profile

More Earnings Resources from MarketBeat